A case of gastric cancer with paraaortic lymph node metastasis responding to TS-1/CDDP as neoadjuvant chemotherapy
Nakamura, M.; Maruyama, K.; Furukawa, J.; Maruyama, N.; Tanaka, J.; Katsumoto, Y.; Yokouchi, H.; Nakaguchi, K.; Sue, F.; Yoshihara, W.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(8): 1431-1436
2002
ISSN/ISBN: 0385-0684 PMID: 12214473 Document Number: 548093
A 64-year-old male visited our hospital with complaints of epigastric pain. Computed tomography (CT) showed gastric cancer with extensive paraaortic lymph node metastasis. We decided that a curative operation was impossible, and administered the following chemotherapy. After 120 mg/day of TS-1 was orally administered for 3 weeks followed by 2 drug-free weeks with 90 mg of CDDP was administered intravenously on day 8, CT showed a 90.6% reduction in the paraaortic lymph node metastasis. No serious adverse reaction was observed. After 2 courses of this chemotherapy, surgery was performed after informed consent was obtained from the patient. Histrogical result showed PR. The patient is now healthy and no sign of recurrence has been observed. TS-1/CDDP therapy is useful for advanced gastric cancer.